For: | Zhou XK, Tang SS, Yi G, Hou M, Chen JH, Yang B, Liu JF, He ZM. RNAi knockdown of PIK3CA preferentially inhibits invasion of mutant PIK3CA cells. World J Gastroenterol 2011; 17(32): 3700-3708 [PMID: 21990951 DOI: 10.3748/wjg.v17.i32.3700] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i32/3700.htm |
Number | Citing Articles |
1 |
R. L. Ross, H. R. McPherson, L. Kettlewell, S. D. Shnyder, C. D. Hurst, O. Alder, M. A. Knowles. PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2570-0
|
2 |
Ayda Baghery Saghchy Khorasani, Atieh Pourbagheri-Sigaroodi, Ali Pirsalehi, Ava Safaroghli-azar, Mohammad Reza Zali, Davood Bashash. The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions. European Journal of Pharmacology 2021; 898: 173983 doi: 10.1016/j.ejphar.2021.173983
|
3 |
Tasuku Matsuoka, Masakazu Yashiro. The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma. Cancers 2014; 6(3): 1441 doi: 10.3390/cancers6031441
|
4 |
Si-Hyong Jang, Kyung-Ju Kim, Mee-Hye Oh, Ji-Hye Lee, Hyun Ju Lee, Hyun Deuk Cho, Sun Wook Han, Myoung Won Son, Moon Soo Lee. Clinicopathological Significance of Elevated PIK3CA Expression in Gastric Cancer. Journal of Gastric Cancer 2016; 16(2): 85 doi: 10.5230/jgc.2016.16.2.85
|
5 |
Zhong-Tian Jin, Kun Li, Mei Li, Zhi-Gang Ren, Fu-Shun Wang, Ji-Ye Zhu, Xi-Sheng Leng, Wei-Dong Yu. G-protein Coupled Receptor 34 Knockdown Impairs the Proliferation and Migration of HGC-27 Gastric Cancer Cells In Vitro. Chinese Medical Journal 2015; 128(4): 545 doi: 10.4103/0366-6999.151114
|
6 |
Xinhui Fu, Hanjie Lin, Xinjuan Fan, Yaxi Zhu, Chao Wang, Zhiting Chen, Xiaoli Tan, Jinglin Huang, Yacheng Cai, Yan Huang. The Spectrum, Tendency and Predictive Value of PIK3CA Mutation in Chinese Colorectal Cancer Patients. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.595675
|
7 |
Julia Kneissl, Anja Hartmann, Nicole Pfarr, Franziska Erlmeier, Thomas Lorber, Simone Keller, Gwen Zwingenberger, Wilko Weichert, Birgit Luber. Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines. Journal of Cancer Research and Clinical Oncology 2017; 143(4): 573 doi: 10.1007/s00432-016-2308-z
|
8 |
Monika Paul-Samojedny, Adam Pudełko, Renata Suchanek-Raif, Małgorzata Kowalczyk, Anna Fila-Daniłow, Paulina Borkowska, Jan Kowalski. Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro. Tumor Biology 2015; 36(5): 3263 doi: 10.1007/s13277-014-2955-0
|
9 |
C.B. Murat, P.B.S. Braga, M.A.H.Z. Fortes, M.D. Bronstein, M.L.C. Corrêa-Giannella, R.R. Giorgi. Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas. Brazilian Journal of Medical and Biological Research 2012; 45(9): 851 doi: 10.1590/S0100-879X2012007500115
|
10 |
Monika Paul-Samojedny, Adam Pudełko, Małgorzata Kowalczyk, Anna Fila-Daniłow, Renata Suchanek-Raif, Paulina Borkowska, Jan Kowalski. Knockdown of AKT3 and PI3KCA by RNA interference changes the expression of the genes that are related to apoptosis and autophagy in T98G glioblastoma multiforme cells. Pharmacological Reports 2015; 67(6): 1115 doi: 10.1016/j.pharep.2015.04.012
|
11 |
Xinkui Liu, Jiarui Wu, Dan Zhang, Kaihuan Wang, Xiaojiao Duan, Ziqi Meng, Xiaomeng Zhang, Yoshiki Mukudai. Network Pharmacology‐Based Approach to Investigate the Mechanisms of Hedyotis diffusa Willd. in the Treatment of Gastric Cancer. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/7802639
|
12 |
Shutao Zheng, Chenchen Yang, Mang Lu, Qing Liu, Tao Liu, Fang Dai, Xiangpeng Gao, Ilyar Sheyhidin, Xiaomei Lu. PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma. Human Pathology 2016; 53: 121 doi: 10.1016/j.humpath.2015.11.013
|